December 26, 2018
The Innovation Network Corporation of Japan (INCJ), a subsidiary of the public-private investment fund Japan Investment Corporation, said on December 25 that it has made a further US$12 million investment in California-headquartered biotech NapaJen Pharma through a third-party share allocation...read more